India's New Covid treatment guidelines drop ivermectin, zinc, vitamins, hydroxychloroquine: DGHS norms at variance with ICMR advisory
Tribune India ^ | 06/10/2021
Posted on 6/10/2021, 6:05:22 PM by SeekAndFind
India on Monday issued a new clinical protocol for Covid treatment and dropped all commonly used treatments for mild patients of the infection, including antibiotics, hydroxychloroquine (HCQ), ivermectin and antiviral drug favipiravir.
No antibiotic for mild cases
- No antibiotics or antiviral drug favipiravir for mild patients
- No steam inhalation (people doing this in excess)
- Hydration, good diet, positive mindset, social connection important for recovery
- Remdesivir, tocilizumab use only in severely ill cases, as per fresh DGHS norms
WHO chief scientist Soumya Swaminathan today hailed the new evidence-based guidelines developed by the Director General of Health Services (DGHS) who said mildly ill Covid patients would be fine with just paracetamol, cough syrup and budesonide inhalation and need not be prescribed any antibiotics or major drugs at all.
This means the currently in use and much prescribed HCQ, favipiravir, ivermectin, azithromycin, doxycycline, zinc and vitamins are not required clinically and have no evidence of benefit.
Mild patients would need investigation and paracetamol if symptoms of fever, cough, fatigue and other classical Covid signs persist or deteriorate. |
